BPC-157 Safety Profile

Safety Overview

BPC-157 (Body Protection Compound 157) is not FDA-approved for any indication. It is not approved for human use in any country. The majority of research on BPC-157 comes from a single research group in Croatia (Sikiric and colleagues), which raises concerns about independent verification of findings.

Level of Evidence: Predominantly animal studies. No completed randomized controlled trials in humans have been published in peer-reviewed journals.

What We Don’t Know

Because BPC-157 has not undergone rigorous human clinical trials, critical safety information remains unknown:

Unknown Factor	Why It Matters
Human pharmacokinetics	Absorption, distribution, metabolism, and excretion in humans are not established
Effective dose range	No scientifically validated dosing guidelines exist
Long-term safety	Effects of chronic use beyond weeks or months are completely unknown
Drug interactions	Potential interactions with medications have not been studied
Contraindications	No established list of conditions where BPC-157 should be avoided
Reproductive safety	Effects on pregnancy, fertility, and development are unknown

Theoretical Safety Concerns

Angiogenesis and Cancer Risk

BPC-157 has demonstrated pro-angiogenic effects (promoting blood vessel formation) in animal studies. While this mechanism could theoretically support healing, it raises concerns:

• Tumor promotion: Angiogenesis is required for tumor growth. The theoretical risk is that BPC-157 could promote growth or metastasis of existing cancers.
• No cancer safety data: No studies have evaluated cancer risk in humans or monitored for tumor development.

Reference: PMID 29964650 discusses angiogenic mechanisms, though not specifically cancer risk.

Lack of Human Safety Monitoring

Without regulatory oversight:

• No standardized adverse event reporting exists
• Long-term outcomes in human users are not tracked
• Potential rare or delayed side effects would not be detected

Product Quality Risks

BPC-157 is sold as a “research chemical” through unregulated vendors. This creates significant risks:

• Purity unknown: Products may contain contaminants, incorrect doses, or different compounds entirely
• No quality control: Manufacturing standards are not enforced
• Batch variability: Consistency between batches cannot be guaranteed
• Mislabeling: No verification that products contain what they claim

Regulatory Status

• FDA Status: Not approved; considered an unapproved drug
• WADA Status: Prohibited in competitive sports (banned substance)
• Legal Status: Sale for human consumption is illegal in many jurisdictions; often sold “for research purposes only”

BPC-157 is not a validated therapy. Anyone considering its use should understand they are participating in an unmonitored self-experiment with unknown risks. This information is for educational purposes only and does not constitute medical advice.